| Literature DB >> 30098713 |
Abstract
Somatostatin receptor imaging constitutes an integral part in neuroendocrine tumor visualization and should, because of its vastly superior performance, use 68Ga-DOTA-somatostatin analogue-PET/computed tomography rather than scintigraphy; it is particularly valuable for detecting metastases to lymph nodes, bone, peritoneum, and liver, which may be missed by morphologic imaging. 18FDG-PET/computed tomography is better suited for G3 and high-G2 neuroendocrine tumors. 18FDG-PET/computed tomography provides prognostic information. Alternative available PET tracers are 18F-DOPA and 11C-5-hydroxytryptophan. To take full advantage of the technique PET/computed tomography should include diagnostic intravenous contrast-enhanced computed tomography. PET/MRI is currently mainly investigational.Entities:
Keywords: (11)C-5-hydroxy-tryptophan; (18)F-Dopa; (68)Ga-Dota-noc,(18)FDG; (68)Ga-Dota-tate; (68)Ga-Dota-toc
Mesh：
Substances：
Year: 2018 PMID： 30098713 DOI： 10.1016/j.ecl.2018.04.003
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN： 0889-8529 Impact factor: 4.741